Molecular control of bone resorption in chronic otitis media with cholesteatoma;Regulacje molekularne procesu niszczenia kości w zapaleniu perlakowym ucha

Otolaryngologia Polska

Volumn 64, Issue 4, 2010, Pages 219-224

  Kuczkowski, Jerzy ^a   Kobierska Gulida, Grazyna ^b   Izycka Świeszewska, Ewa ^b   Potocka, Matgorzata ^a   Mikaszewski, Bogusfaw ^a   Sierszerí, Wojciech ^a  

^a Katedra i Klinika Chorob Uszu Nosa Gardla   (Poland)

^b Katedra i Zak ad Patomorfologil   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; CHOLESTEATOMA; COMPLICATION; DISEASE COURSE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; OSTEOLYSIS; OTITIS MEDIA; PATHOLOGY; POLAND; PROGNOSIS; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; AGED; BONE RESORPTION; CHOLESTEATOMA, MIDDLE EAR; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OSTEOPROTEGERIN; OTITIS MEDIA; POLAND; PROGNOSIS; RANK LIGAND; RETROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77958040389     PISSN: 00306657     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0030-6657(10)70019-6     Document Type: Article

References (24)

1. Abramson M, Moriyama H, Huang CC. Pathogenic factor in bone resorption in cholesteatoma. Acta Otolaryngol (Stockh) 1984; 97: 437-42.
2. Aklmoto R, Pawankar R, Yagi T, Baba S. Acquired and congenital cholesteatoma: determination of tumor necrosis factoralfa, intercellular adhesion molecule-1, lnterleukln-1-alfa and lymphocyte functional antigen-1 In the inflammatory process. ORL J Otorhlnolaryngol Relat Spec. 2000; 62: 257-65.
3. Amar MS, Wishahl HF, Zakhary MM. Clinical and biochemical studies of bone destruction in cholesteatoma. J Laryngol Otol. 1996; 110:534-39.
4. Jung JY, Chole RA. Bone resorption in chronic otitis media: The role of osteoclast. ORL J Otorhlnolaryngol Relat Spec. 2002; 64: 95-105.
5. Chole RA. Chronic otitis media, mastoiditis and petrositis. W: Cummings Ch, Fredrikson J, Harker L, Krause Ch, Schuller D, red. Ear and cranial base.Vol.4: Otolaryngology - head and neck surgery. 2nd ed. Mosby Year Book, St Louis USA; 1993. s. 2823-39.
6. Thomsen J. Jorgensen B, Breatlau R Krlstensen HK. Bone resorption in chronic otitis media. Histological and ultrastructural study. II. Cholesteatoma. J Laryngol Otol 1974; 88: 983-92.
7. Chole R. A. Mechanisms of osteoclast activation in cholesteatoma. W: Cholesteatoma and mastoid surgery, red. Tos M. Thomsen J, Peitersen E, Kugler & Ghedini Publications; Amsterdam; 1989, s. 185-90.
8. Moriyama H, Yabe T, Honda Y. Role of fibroblast-like cells on bone resorption in chronic otitis media with or without cholesteatoma. Effects of epidermal growth factor on fibroblast -like cells. W: Cholesteatoma and mastoid surgery, red. Tos M, Thomsen J, Peitersen E. Kugler & Ghedini Publications; Amsterdam; 1989, 191-96.
9. Yan S, Huang C. The role of tumor necrosis factor in bone resorption of cholesteatoma. Am J Otolaryngol. 1991; 100: 85-88.
10. Yetiser S, Satar B, Aydin N. Expression of epidermal growth factor, tumor necrosis factor-a, and interleukln-la in chronic otitis media with or without cholesteatoma. Otol Neurotol. 2002; 23: 647-52.
11. Chodynicki S, Chyczewski L, Olszewska E. Immunohistochemical investigations of cathepsin D in the structures of cholesteatoma. Med Sci. Monit. 2002; 8:184-86.
12. Hamzei, M., Ventriglia, G., Hagnla, M. i wsp. Osteoclast stimulating and differentiating factors in human cholesteatoma. Laryngoscope. 2003; 113: 436-42.
13. Jeong Jin-Hyeok; Park Chul-Won; Tae Kyung Lee, et al. Expression of RANKL and OPG in Middle Ear Cholesteatoma Tissue. Laryngoscope. 2006: 116: 1180-84.
14. Jung JY, Pashia ME, Nishimoto SY, Faddis BT, Chole RA. A possible role for nitric oxide in osteoclastogenesls associated with cholesteatoma. Otol Neurotol 2004; 25:661-66.
15. Cinamon U, Kronrnberg J, Benayahu D. Structural changes and protein expression in the mastoid bone adjacent to cholesteatoma. Laryngoscope. 2000; 110: 1198-1203.
16. Kanzakl S, Ito M, Takada Y, Ogawa K, Matsuo K. Resorption of auditory ossicles and hearing loss in mice lacking osteoprotegerin. Bone 2006; 39: 414-19.
17. Hsu SM, Raine L, Fanger H. Use of avidin-biotln-peroxidase complex (ABC) in immunoperoxldase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem. 1981; 29: 577-80.
18. Gantz B, Maynard J. Ultrastructural evaluation of biochemical events of bone resorption In human chronic otitis media. Am J Otol. 1982; 3: 279-83.
19. Theoleyre S, Wittrant Y, Tat SK, Fortun Y, Redini F, Heymann D. The molecular triad OPG/RANK/RANKL involvement in the orchestration of pathophysiological bone remodelling. Cytokine Growt Factor Rev. 2004; 15: 457-75.
20. Grimaud E, Soubigou L, Couillaud S. i wsp. Receptor activator of nuclear factor KB ligand (RANKL)/Osteoprotegerin (OPG). Ratio is increased in severe osteolysis. Am J Pathol. 2003; 163:2021-31.
21. Stawinska N, Ziçtek M, Kochanowska I. Molekularne procesy resorpcjl kości i ich potencjal terapeutyczny w leczeniu chorob przyzçbia i osteoporozy. Dent Med Probl. 2005; 42: 627-35.
22. Miyao M, Shinoda H, Takahashi S. Caspase-3, Caspase-8, and nuclear factor-KB expression in human cholesteatoma. Otol Neurotol. 2005; 27: 8-13.
23. Sudhoff H. Liebehenz Y, Aschenbrenner J, Jung J. Hildmann H, Dazert S. A murine model of cholesteatoma-induced bone resorption using autologus dermal Implantation. Laryngoscope. 2003; 113: 1022-26.
24. Olszewska E, Olszewski S, Sieśkiewlcz A, Borzym-Kluczyk M, Lazarczyk B, Sudhoff H. Regulatory osteoklastogenezy w perlaku ucha środkowego. Otorynolaryngologla 2006; 5: 140-44.